HOME >> BIOLOGY >> NEWS
LDL receptor reduces LDL production, removes cholesterol from blood

MADISON -- A cell membrane protein thought mainly to bind "bad" cholesterol and remove it from circulation also plays a major role in reducing the production of that cholesterol, according to a study published this February in the Journal of Clinical Investigation.

The University of Wisconsin-Madison study provides new insights into the nature of lipoprotein overproduction in people with familial hypercholesterolemia (FH), an inherited disease that affects one in 500 people. The research also explains how statins, a class of medications taken by several million Americans, work to lower blood cholesterol levels.

Low-density lipoprotein (LDL) carries cholesterol to other cells in the body that need it. People whose blood levels of LDL -- the "bad" cholesterol -- are too high have an increased risk of heart disease. Individuals with FH have extremely high levels of LDL and are at high risk for heart attacks at an early age.

"In the 1970s researchers discovered that the LDL receptor is responsible for removing most of the cholesterol from blood," according to Alan Attie, a biochemist in the UW-Madison College of Agricultural and Life Sciences. "They showed that a mutation in the gene that codes for the LDL receptor causes FH. Most people thought that the receptor's major function was to clear LDL from blood."

However, scientists later found that people with FH have high LDL levels not only because they clear it from their blood too slowly, but also because they produce too much, Attie says. "Ours is the first study that explains the paradox of why people with FH produce too much LDL," he says. "We showed that functional LDL receptors increase the degradation of apolipoprotein B inside liver cells."

Apolipoprotein B (apoB) is the major protein component of very low-density lipoprotein, which is made by liver cells and converted to LDL in the blood. The rate of apoB production in liver cells -- and thus LDL production -- is determined by how much a
'"/>

Contact: Alan Attie
attie@biochem.wisc.edu
608-262-1372
University of Wisconsin-Madison
4-Apr-2000


Page: 1 2 3

Related biology news :

1. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
2. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
3. Two-pronged attack targeting EGF receptor hinders cancer cell growth
4. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
5. Dioxin-receptor network identified
6. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
7. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus
8. Activation of receptor ups development of precancerous intestinal polyps
9. Researchers find an association between alcohol dependence and the GABAA receptor gene GABRG3
10. The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?
11. Estrogen receptor-a disruption and vasodilation in coronary arteries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... , ... February 04, 2019 , ... ... new Explorer™ story which provides insights to help individuals understand how the gut ... cardiovascular wellness. , After individuals eat foods that contain choline and L-carnitine, ...
(Date:2/2/2019)... ... January 31, 2019 , ... Aperio ... customizable clinical research services across multiple therapeutic areas, announced an Innovation Partner ... life science entrepreneurs in the Research Triangle region of North Carolina. ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., ... Survey. The report indicates membership growth in some sectors and decreasing membership among ... received responses from over 500 association professionals across North America. , “This ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... 2019 , ... Personalized treatment plans may extend life expectancy for early-stage kidney ... study published in the journal Radiology. , Kidney, or renal, tumors are often ... procedure in which the tumor and part of the kidney are removed. However, some ...
(Date:1/11/2019)... ... ... Drawing on over 22 years of software development expertise, the live webinar ... the key lessons that have driven customer satisfaction with their eClinical suite. Explore the ... how to ensure that you continue to be able to take advantage of the ...
(Date:1/10/2019)... ... 2019 , ... VGI Medical was founded in 2007 based on an invention ... the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are ... dual geometric design to limit motion of the affected spinal segment. Applying the principles ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... 1 clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 ... Parkinson's Disease. The trial took place in South Korea. , This Phase ...
Breaking Biology Technology:
Cached News: